Journal article
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors
A Joan Levine, Amanda I Phipps, John A Baron, Daniel D Buchanan, Dennis J Ahnen, Stacey A Cohen, Noralane M Lindor, Polly A Newcomb, Christophe Rosty, Robert W Haile, Peter W Laird, Daniel J Weisenberger
Cancer Epidemiology Biomarkers & Prevention | AMER ASSOC CANCER RESEARCH | Published : 2016
Grants
Awarded by NIH/NCI
Awarded by NCI
Awarded by Australasian Colorectal Cancer Family Registry
Awarded by USC Consortium Colorectal Cancer Family Registry
Awarded by Mayo Clinic Cooperative Family Registry for Colon Cancer Studies
Awarded by Ontario Registry for Studies of Familial Colorectal Cancer
Awarded by Seattle Colorectal Cancer Family Registry
Funding Acknowledgements
This work was supported by NIH/NCI grant R01 CA118699 (to P.W. Laird). This work was also supported by grant UM1 CA167551 (to R.W. Haile, M.A. Jenkins, N.M. Lindor) from the NCI and through the cooperative agreements with the following CCFR centers: Australasian Colorectal Cancer Family Registry (U01 CA074778, to J.R. Jass; U01/U24 CA097735, to J.L. Hopper), USC Consortium Colorectal Cancer Family Registry (U01/U24 CA074799; to R.W. Haile), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01/U24 CA074800; to N.M. Lindor), Ontario Registry for Studies of Familial Colorectal Cancer (U01/U24 CA074783; to S. Gallinger), and Seattle Colorectal Cancer Family Registry (U01/U24 CA074794; to J.D. Potter and P.A. Newcomb). The Jeremy Jass Memorial Pathology Bank provided CCFR paraffin-embedded tissue and pathology-related variables for this study.